During Thursday’s trading session, even as Sensex and Nifty were trading negative, the stock of Larsen & Toubro was trading positive.

GPT Infraprojects Limited (GPT) has announced that it has bagged an order valued at Rs 162.83 crore.

Hero Motocorp, sold more than 14 lakh units of motorcycles and scooters, in retail sales during the just concluded festive season, which helped it in gaining market share and strengthen its leadership. The company's market share has grown by more than 500 bps in the month of October.

The Nifty PSU Bank index, which is known as the backbenchers of the market has surged above its 200-DMA for the first time after July 22, 2019. The index was trading below its crucial 200-DMA level since last 329 trading sessions.

On Wall Street, the stocks cracked impulsively in the second half of trading session and the Asian peers too are feeling the pinch and this weakness will inevitably spill on the Indian shores as well. The SGX Nifty is indicating a scary fall on D-Street as it has cracked 136 points or 1.05 per cent and was trading at 12,857 levels.

As the Nifty is nearing the pattern targets, the upside move could be limited from the current levels. It may test 13000-13200 levels, but beyond this point it is challenging to forecast.

During Wednesday’s trading session, the stock of Gayatri Projects jumped by more than 4 per cent and made an intraday high of 30.35. Shares of Gayatri Projects have gained by 26 per cent in the last five trading days.

With this trendline breakout, the stock after a span of over six months has managed to successfully close above its crucial long-term moving average i.e. 200-day EMA. The stock has also managed to close above Upper Bollinger band and started band walk, which is very bullish sign.

On Wednesday, domestic benchmark indices continued their gaining momentum. Sensex gained by 227.34 points or 0.52 per cent to settle at 44180.05 levels while Nifty rose by 64.05 points or 0.50 per cent to close at 12938.25 levels.

With extensive reach, partnership and network with the public health authorities and other institutions, Cipla will be ensure uninterrupted access of these kits across more than 25 markets in Asia, Australia, Europe, Middle East, North Africa and Latin America.